RE:RE:RE:RE:RE:RE:Inventory write down???Just a hunch, but I expect that LABS focused on jurisdictions that had greater clarity in their approach to this sector. The US really didn't have any consistent or universal approval/approach.
I would expect that they have been in talks with Stada like outfits in the US....but who knows.
After the Stada deal, I really did (and do) hope that a like deal in the US is in the works. How awesome would it be if Pfizer or J&J or whoever was a trusted pharma partner....lol
Bains may well be greasing that wheel too....
bitscounter wrote:
Just wondering, are there any plans for LABS partnering with US pharmaceuticals or US MSO's? We keep hearing about European/Australian partners but none in the US so far.